Roivant Sciences Ltd. Share Price Today: Live Updates & Key Insights
Roivant Sciences Ltd. share price today is $28, up -0.36%. The stock opened at $27.95 against the previous close of $27.8, with an intraday high of $27.95 and low of $27.12.
Roivant Sciences Ltd. Share Price Chart
Roivant Sciences Ltd.
Roivant Sciences Ltd. Share Price Performance
Roivant Sciences Ltd. Institutional Holdings
Roivant Sciences Ltd. Market Status
Roivant Sciences Ltd. Fundamentals
Market Cap 19824.92 M
PB Ratio 4.642
PE Ratio 0.0
Enterprise Value 15396.73 M
Total Assets 5436.94 M
Volume 20864203
Roivant Sciences Ltd. Company Financials
About Roivant Sciences Ltd. & investment objective
Company Information Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody that targets the neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising lipid nanoparticle (LNP) platform and ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.
Organisation Biotechnology
Employees 750
Industry Biotechnology
CEO Dr. Eric Venker M.D., Pharm.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Roivant Sciences Ltd. FAQs
What is the share price of Roivant Sciences Ltd. today?
The current share price of Roivant Sciences Ltd. is $28.
Can I buy Roivant Sciences Ltd. shares in India?
Yes, Indian investors can buy Roivant Sciences Ltd. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Roivant Sciences Ltd. shares in India?
You can easily invest in Roivant Sciences Ltd. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Roivant Sciences Ltd. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Roivant Sciences Ltd..
Can I buy fractional shares of Roivant Sciences Ltd.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Roivant Sciences Ltd.?
Roivant Sciences Ltd. has a market cap of $19824.92 M.
In which sector does Roivant Sciences Ltd. belong?
Roivant Sciences Ltd. operates in the Biotechnology sector.
What documents are required to invest in Roivant Sciences Ltd. stocks?
To invest, you typically need:
What is the PE and PB ratio of Roivant Sciences Ltd.?
The PE ratio of Roivant Sciences Ltd. is N/A and the PB ratio is 4.64.